"Carcinoma, Basal Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
| Descriptor ID |
D002280
|
| MeSH Number(s) |
C04.557.470.200.165 C04.557.470.565.165
|
| Concept/Terms |
Carcinoma, Basal Cell- Carcinoma, Basal Cell
- Basal Cell Carcinoma
- Basal Cell Carcinomas
- Carcinomas, Basal Cell
- Rodent Ulcer
- Rodent Ulcers
- Ulcers, Rodent
- Ulcer, Rodent
- Epithelioma, Basal Cell
- Basal Cell Epithelioma
- Basal Cell Epitheliomas
- Epitheliomas, Basal Cell
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Basal Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Basal Cell".
This graph shows the total number of publications written about "Carcinoma, Basal Cell" by people in this website by year, and whether "Carcinoma, Basal Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 2 | 8 |
| 1995 | 6 | 2 | 8 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 3 | 5 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 5 | 4 | 9 |
| 2006 | 1 | 4 | 5 |
| 2007 | 5 | 2 | 7 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 6 | 3 | 9 |
| 2011 | 7 | 2 | 9 |
| 2012 | 4 | 2 | 6 |
| 2013 | 4 | 0 | 4 |
| 2014 | 7 | 0 | 7 |
| 2015 | 10 | 1 | 11 |
| 2016 | 9 | 1 | 10 |
| 2017 | 14 | 2 | 16 |
| 2018 | 6 | 1 | 7 |
| 2019 | 12 | 0 | 12 |
| 2020 | 6 | 1 | 7 |
| 2021 | 6 | 0 | 6 |
| 2022 | 3 | 0 | 3 |
| 2023 | 5 | 0 | 5 |
| 2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Basal Cell" by people in Profiles.
-
Current and emerging intralesional immunotherapies in cutaneous oncology. J Am Acad Dermatol. 2024 Nov; 91(5):910-921.
-
A Tale of Two Tumors: A Collision Tumor of Atypical Fibroxanthoma and Basal Cell Carcinoma. Am J Dermatopathol. 2024 May 01; 46(5):309-311.
-
Treatments on the horizon for locally advanced basal cell carcinoma. Cancer Lett. 2024 May 01; 589:216821.
-
Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nat Med. 2024 Mar; 30(3):690-698.
-
Association of Hereditary Hemochromatosis With Nonmelanoma Skin Cancer: A Population-Based Nested Case-Control Study. Dermatol Surg. 2024 May 01; 50(5):483-484.
-
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2024 Jun; 90(6):1243-1245.
-
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors. Ann Oncol. 2024 Feb; 35(2):221-228.
-
Skin Cancers in Medicare Beneficiaries With Actinic Keratoses. JAMA Dermatol. 2023 12 01; 159(12):1368-1372.
-
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up. J Am Acad Dermatol. 2024 Feb; 90(2):414-418.
-
Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study. Eur J Dermatol. 2023 Jun 01; 33(3):280-286.